The microRNA inhibitor CDR132L in patients with reduced left ventricular ejection fraction after myocardial infarction: a randomized phase 2 trial

Journal:
Nature Medicine
Published:
Affiliations:
13
Authors:
14
Institutions Authors Share
Novo Nordisk, Denmark
3.000000
0.21
Hannover Medical School (MHH), Germany
1.500000
0.11
CARDIOR Pharmaceuticals GmbH, Germany
1.500000
0.11
Brigham and Women's Hospital (BWH), United States of America (USA)
1.000000
0.07
DZHK Partner Site Berlin, Germany
1.000000
0.07
Hospital Universitario La Luz, Spain
1.000000
0.07
Erasmus University Medical Center (Erasmus MC), Netherlands
1.000000
0.07
University General Hospital Attikon, Greece
1.000000
0.07
Wroclaw Medical University, Poland
1.000000
0.07
University of Minnesota (UMN), United States of America (USA)
1.000000
0.07
University Medical Center Göttingen (UMG), Germany
0.500000
0.04
DZHK Partner Site Lower Saxony, Germany
0.500000
0.04